Active ingredient
Trastuzumab NDC Codes
Trastuzumab is an active ingredient in 12 finished products listed with the FDA, under 8 names.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Brand and generic names
- Ogivri, Phesgo, Kanjinti, Ontruzant, Trazimera, Herzuma, Herceptin Hylecta, Herceptin
- Labelers
- Genentech, Inc., Biocon Biologics Inc., Amgen, Inc, Organon LLC, Pfizer Laboratories Div Pfizer Inc, Cephalon, Inc., Mylan Institutional LLC
- Strengths
- Trastuzumab 150 mg/7.4mL; Trastuzumab 150 mg/7.15mL; Trastuzumab 420 mg/20mL; Trastuzumab 150 mg/1; Pertuzumab 1200 mg/15mL; Trastuzumab 600 mg/15mL; Hyaluronidase (Human recombinant) 30000 U/15mL; Pertuzumab 600 mg/10mL; Trastuzumab 600 mg/10mL; Hyaluronidase (Human recombinant) 20000 U/10mL; Trastuzumab 600 mg/5mL; Hyaluronidase (Human recombinant) 10000 U/5mL
- Dosage forms
- Injection, Powder, Lyophilized, For solution, Injection, Solution
- Routes
- Intravenous, Subcutaneous
- Drug classes (FDA established)
- HER2/neu Receptor Antagonist, Endoglycosidase
- Package NDCs
- 15
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Ogivritrastuzumab-dkst | Trastuzumab 150 mg/7.4mL | Injection, Powder, Lyophilized, For solutionIntravenous | Biocon Biologics Inc. | 83257-001 | 83257-0001-11 | J9355 |
| Ogivritrastuzumab-dkst | Trastuzumab 420 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | Biocon Biologics Inc. | 83257-003 | — | J9355 |
| Ontruzanttrastuzumab | Trastuzumab 150 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | Organon LLC | 78206-147 | 78206-0147-01 | J9355 |
| Trazimeratrastuzumab-qyyp | Trastuzumab 150 mg/7.15mL | Injection, Powder, Lyophilized, For solutionIntravenous | Pfizer Laboratories Div Pfizer Inc | 0069-0308 | 00069-0308-01 | J9355 |
| Phesgopertuzumab, trastuzumab, and hyaluronidase-zzxf | Pertuzumab 1200 mg/15mL + 2 more ingredients | Injection, SolutionSubcutaneous | Genentech, Inc. | 50242-245 | 50242-0245-0150242-0245-86 | — |
| Phesgopertuzumab, trastuzumab, and hyaluronidase-zzxf | Pertuzumab 600 mg/10mL + 2 more ingredients | Injection, SolutionSubcutaneous | Genentech, Inc. | 50242-260 | 50242-0260-0150242-0260-86 | — |
| Herzumatrastuzumab | Trastuzumab 150 mg/7.15mL | Injection, Powder, Lyophilized, For solutionIntravenous | Cephalon, Inc. | 63459-303 | 63459-0303-43 | J9355 |
| Ogivritrastuzumab | Trastuzumab 150 mg/7.4mL | Injection, Powder, Lyophilized, For solutionIntravenous | Mylan Institutional LLC | 67457-991 | 67457-0991-15 | J9355 |
| Kanjintitrastuzumab-anns | Trastuzumab 150 mg/7.15mL | Injection, Powder, Lyophilized, For solutionIntravenous | Amgen, Inc | 55513-141 | 55513-0141-0155513-0141-21 | J9355 |
| Kanjintitrastuzumab-anns | Trastuzumab 420 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | Amgen, Inc | 55513-132 | 55513-0132-0155513-0132-21 | J9355 |
| Herceptin Hylectatrastuzumab and hyaluronidase-oysk | Trastuzumab 600 mg/5mL; Hyaluronidase (Human recombinant) 10000 U/5mL | Injection, SolutionSubcutaneous | Genentech, Inc. | 50242-077 | 50242-0077-01 | — |
| Herceptintrastuzumab | Trastuzumab 150 mg/7.4mL | Injection, Powder, Lyophilized, For solutionIntravenous | Genentech, Inc. | 50242-132 | 50242-0132-01 | J9355 |
Trastuzumab: common questions
- Which drugs contain Trastuzumab?
- Ogivri, Phesgo, Kanjinti, Ontruzant, Trazimera, Herzuma, Herceptin Hylecta, Herceptin.
- Is there a J-code for Trastuzumab?
- Med-Code's HCPCS directory matches J9355 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.